ABBOTT INDIA
Back to Income Statement
|
ABBOTT INDIA Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹6,409 Cr | ₹5,849 Cr | ₹5,349 Cr | ₹4,913 Cr | ₹4,310 Cr |
What is the latest Revenue of ABBOTT INDIA ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹6,409 Cr |
| Mar2024 | ₹5,849 Cr |
| Mar2023 | ₹5,349 Cr |
| Mar2022 | ₹4,913 Cr |
| Mar2021 | ₹4,310 Cr |
How is Revenue of ABBOTT INDIA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹6,409 Cr | 9.58 | |
| Mar2024 | ₹5,849 Cr | 9.35 | |
| Mar2023 | ₹5,349 Cr | 8.86 | |
| Mar2022 | ₹4,913 Cr | 14.00 | |
| Mar2021 | ₹4,310 Cr | - | |
Compare Revenue of peers of ABBOTT INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ABBOTT INDIA | ₹58,501.8 Cr | 5.3% | 1.8% | -10.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,777.0 Cr | -0.8% | 7.4% | 8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,931.0 Cr | -1.5% | 5.7% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,330.0 Cr | -1.8% | 8.8% | 44.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,593.0 Cr | -1.2% | 9.2% | 14.9% | Stock Analytics | |
| CIPLA | ₹107,112.0 Cr | -2.5% | 0.1% | -7.6% | Stock Analytics | |
ABBOTT INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ABBOTT INDIA | 5.3% |
1.8% |
-10.8% |
| SENSEX | -2.8% |
-2% |
7.3% |
You may also like the below Video Courses